YU262380A - Process for obtaining piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrol-2-carboxylic acid - Google Patents

Process for obtaining piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrol-2-carboxylic acid

Info

Publication number
YU262380A
YU262380A YU02623/80A YU262380A YU262380A YU 262380 A YU262380 A YU 262380A YU 02623/80 A YU02623/80 A YU 02623/80A YU 262380 A YU262380 A YU 262380A YU 262380 A YU262380 A YU 262380A
Authority
YU
Yugoslavia
Prior art keywords
dialkyl
hydroxy
carboxylic acid
pyrrol
piperidine derivatives
Prior art date
Application number
YU02623/80A
Other languages
English (en)
Inventor
F F Frickel
A Franke
G Philipsborn
C Mueller
D Lenker
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of YU262380A publication Critical patent/YU262380A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
YU02623/80A 1979-10-13 1980-10-13 Process for obtaining piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrol-2-carboxylic acid YU262380A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792941597 DE2941597A1 (de) 1979-10-13 1979-10-13 Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
YU262380A true YU262380A (en) 1983-01-21

Family

ID=6083464

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02623/80A YU262380A (en) 1979-10-13 1980-10-13 Process for obtaining piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrol-2-carboxylic acid

Country Status (18)

Country Link
US (1) US4315939A (fr)
EP (1) EP0027928B1 (fr)
JP (1) JPS5663956A (fr)
AT (1) ATE2746T1 (fr)
AU (1) AU532982B2 (fr)
CA (1) CA1155124A (fr)
CS (1) CS214759B2 (fr)
DE (2) DE2941597A1 (fr)
DK (1) DK430380A (fr)
ES (1) ES495831A0 (fr)
FI (1) FI70013C (fr)
HU (1) HU184936B (fr)
IE (1) IE50796B1 (fr)
IL (1) IL61212A (fr)
NO (1) NO803047L (fr)
SU (1) SU957768A3 (fr)
YU (1) YU262380A (fr)
ZA (1) ZA806282B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3276313D1 (en) * 1981-09-24 1987-06-19 Beecham Wuelfing Gmbh & Co Kg Sulphonamides
US4567264A (en) * 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
US4558129A (en) * 1983-05-18 1985-12-10 Syntex (U.S.A.) Inc. Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade
US6242450B1 (en) * 1998-07-27 2001-06-05 Eli Lilly And Company 5-HT1F antagonists
WO2000006082A2 (fr) * 1998-07-27 2000-02-10 Eli Lilly And Company Traitement des troubles anxieux
TW201209043A (en) * 2010-05-17 2012-03-01 Glaxo Group Ltd Novel processes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1527E (fr) * 1902-08-20 1903-08-12 Hermann Hilbert Procédé pour extrait la gélatine et la colle des os
DE1720033A1 (de) * 1966-03-02 1971-05-19 Yoshitomi Pharmaceutical Neue Indolderivate und Verfahren zu ihrer Herstellung
CH481104A (de) * 1967-01-25 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von neuen Indolderivaten
US3860609A (en) * 1969-05-27 1975-01-14 Novo Terapeutisk Labor As 3-aminoalkyloxyindoles
DE2630152A1 (de) * 1976-07-05 1978-01-19 Cassella Farbwerke Mainkur Ag Derivate des 1-phenoxy-propan-2-ols- und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ES8200363A1 (es) 1981-11-01
DE2941597A1 (de) 1981-04-23
IE802102L (en) 1981-04-13
JPS5663956A (en) 1981-05-30
IE50796B1 (en) 1986-07-23
ES495831A0 (es) 1981-11-01
HU184936B (en) 1984-11-28
ZA806282B (en) 1981-10-28
IL61212A0 (en) 1980-12-31
DK430380A (da) 1981-04-14
FI802960A (fi) 1981-04-14
JPS648632B2 (fr) 1989-02-14
EP0027928A2 (fr) 1981-05-06
IL61212A (en) 1983-09-30
NO803047L (no) 1981-04-14
ATE2746T1 (de) 1983-03-15
CS214759B2 (en) 1982-05-28
CA1155124A (fr) 1983-10-11
FI70013B (fi) 1986-01-31
US4315939A (en) 1982-02-16
AU6320480A (en) 1981-04-16
EP0027928B1 (fr) 1983-03-09
FI70013C (fi) 1986-09-12
DE3062300D1 (en) 1983-04-14
EP0027928A3 (en) 1981-05-20
AU532982B2 (en) 1983-10-20
SU957768A3 (ru) 1982-09-07

Similar Documents

Publication Publication Date Title
HUT54144A (en) Process for producing 3-desmethylmevalonic acid derivatives and pharmaceutical compositions comprising same as active ingredient
ES467931A1 (es) Procedimiento para la obtencion de piridinil-aminoalquilete-res
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
YU262380A (en) Process for obtaining piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrol-2-carboxylic acid
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
ZA807789B (en) Piperidine derivatives,their preparation,and pharmaceutical formulations containing these compounds
JPS56110679A (en) 55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it
NO175637C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-fluor-3,5-dihydroksykarboksylsyrer og derivater derav
JPS5545681A (en) 88chloroo66hydroxyy55methylbenzoic acid derivative
HUT44802A (en) Process for producing pseudo-oligosaccharides and pharmaceutical compositions containing them
IL61274A (en) Amino derivatives of 5-(2-hydroxystyryl)-isoxazole,their preparation and pharmaceutical compositions containing them
EP0389773A3 (fr) Procédé de préparation d'une composition pharmaceutique de phénonoxime-2-hydroxy-5-méthyllauro avec de la biodisponibilité optimale
IE780207L (en) 4-hydroxy-1,2-benzisothiazole